Knoa Pharma
This executive role provides enterprise-wide oversight of an ethics and compliance program aligned with DOJ and HHS-OIG standards for a pharmaceutical company. The position focuses on managing monitorship obligations, mitigating compliance risks related to opioid manufacturing, and serving as a strategic business partner to various operational units.
Knoa Pharma is a new for-profit, private company – dedicated at its core – to a purpose of developing and bringing to market medicines to reverse opioid overdoses and treat opioid use disorder
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Knoa Pharma.
Knoa Pharma didn’t post a salary, so this is our estimate from similar listings.